LifeVantage Announces Closing of LoveBiome Acquisition
LifeVantage (Nasdaq:LFVN) has completed its acquisition of LoveBiome, a direct sales company specializing in microbiome care and wellness solutions. The strategic acquisition includes LoveBiome's core operating assets and key personnel retention.
The merger combines LoveBiome's innovative P84 product and microbiome solutions with LifeVantage's Activation technologies, strengthening the company's position in the growing gut health market. The deal expands LifeVantage's market presence in the US, Taiwan, and Europe, with LoveBiome's founder Kelly Olsen joining forces to drive growth initiatives.
LifeVantage (Nasdaq:LFVN) ha completato l'acquisizione di LoveBiome, un'azienda di vendita diretta specializzata nella cura del microbioma e nelle soluzioni per il benessere. L'acquisizione strategica comprende gli asset operativi principali di LoveBiome e il mantenimento del personale chiave.
La fusione unisce l'innovativo prodotto P84 di LoveBiome e le soluzioni per il microbioma alle tecnologie di Activation di LifeVantage, rafforzando la posizione dell'azienda nel dinamico mercato della salute intestinale. L'accordo amplia la presenza di LifeVantage negli Stati Uniti, a Taiwan e in Europa, con il fondatore di LoveBiome, Kelly Olsen, che si unisce per guidare le iniziative di crescita.
LifeVantage (Nasdaq:LFVN) ha completado la adquisición de LoveBiome, una empresa de venta directa especializada en cuidado del microbioma y soluciones de bienestar. La adquisición estratégica incluye los activos operativos principales de LoveBiome y la retención del personal clave.
La fusión combina el innovador producto P84 de LoveBiome y soluciones para el microbioma con las tecnologías de Activación de LifeVantage, fortaleciendo la posición de la empresa en el creciente mercado de la salud intestinal. El acuerdo amplía la presencia de LifeVantage en EE. UU., Taiwán y Europa, con el fundador de LoveBiome, Kelly Olsen, uniéndose para impulsar las iniciativas de crecimiento.
LifeVantage (Nasdaq:LFVN)은 LoveBiome을 인수하는 거래를 마무리했습니다. LoveBiome은 마이크로바이옴 관리 및 웰빙 솔루션을 전문으로 하는 Direct 판매 회사입니다. 이번 전략적 인수에는 LoveBiome의 핵심 운영 자산과 핵심 인력의 유지가 포함됩니다.
합병은 LoveBiome의 혁신적인 P84 제품과 마이크로바이옴 솔루션을 LifeVantage의 Activation 기술과 결합되어, 성장하는 장 건강 시장에서 회사의 위치를 강화합니다. 이 거래는 LifeVantage의 미국, 대만 및 유럽에서의 시장 입지를 확장하며, LoveBiome의 창립자 Kelly Olsen이 성장 이니셔티브를 주도하기 위해 합류합니다.
LifeVantage (Nasdaq:LFVN) a finalisé l'acquisition de LoveBiome, une société de vente directe spécialisée dans les soins du microbiome et les solutions de bien-être. L'acquisition stratégique comprend les actifs opérationnels principaux de LoveBiome et le maintien du personnel clé.
La fusion associe le produit innovant P84 de LoveBiome et les solutions liées au microbiome aux technologies d'Activation de LifeVantage, renforçant la position de l'entreprise sur le marché en croissance de la santé intestinale. L'accord élargit la présence de LifeVantage sur les États-Unis, Taïwan et l'Europe, avec la fondatrice de LoveBiome, Kelly Olsen, qui se joint à l'équipe pour conduire les initiatives de croissance.
LifeVantage (Nasdaq:LFVN) hat die Übernahme von LoveBiome abgeschlossen, einem Direktvertriebsunternehmen, das sich auf Mikrobiom-Pflege und Wellness-Lösungen spezialisiert hat. Die strategische Übernahme umfasst LoveBiomes Kerngeschäftsvermögen und die Bindung der wichtigsten Mitarbeiter.
Die Fusion verbindet LoveBiomes innovatives P84-Produkt und Mikrobiom-Lösungen mit LifeVantages Activation-Technologien und stärkt die Position des Unternehmens im wachsenden Markt für Darmgesundheit. Der Deal erweitert LifeVantages Marktpräsenz in den USA, Taiwan und Europa, wobei LoveBiomes Gründerin Kelly Olsen dem Team beitritt, um Wachstumsinitiativen voranzutreiben.
LifeVantage (Nasdaq:LFVN) أكملت الاستحواذ على LoveBiome، وهي شركة مبيعات مباشرة تختص بالعناية بالميكروبيوم وحلول العافية. يشمل الاستحواذ الاستراتيجي أصول LoveBiome التشغيلية الرئيسية مع الاحتفاظ بالموظفين الأساسيين.
تدمج الصفقة منتج P84 المبتكر من LoveBiome وحلول الميكروبيوم مع تقنيات Activation من LifeVantage، مما يعزز موقع الشركة في السوق المتنامي لصحة الأمعاء. توسيع الاتفاق حضور LifeVantage في الولايات المتحدة وتايوان وأوروبا، مع انضمام المؤسس Kelly Olsen لدفع مبادرات النمو.
LifeVantage (Nasdaq:LFVN) 已完成对 LoveBiome 的收购，这是一家专注于微生物组护理与健康解决方案的直销公司。此次战略收购包括 LoveBiome 的核心运营资产以及关键人员的保留。
合并将 LoveBiome 的创新 P84 产品 与微生物组解决方案，与 LifeVantage 的 Activation 技术结合，强化公司在日益增长的肠道健康市场的地位。此交易扩大了 LifeVantage 在 美国、台湾和欧洲 的市场影响力，LoveBiome 的创始人 Kelly Olsen 将携手推动增长计划。
- Strategic expansion into rapidly growing gut health market
- Geographic expansion in US, Taiwan, and Europe markets
- Acquisition of innovative P84 product and microbiome solutions
- Retention of key LoveBiome personnel including founder
- Complementary product portfolio integration with existing Activation technologies
- Financial terms and transaction value not disclosed
- Integration costs and potential operational challenges not addressed
Insights
LifeVantage closes LoveBiome acquisition to expand into growing microbiome market, strengthening product portfolio and geographical reach.
LifeVantage has finalized its acquisition of LoveBiome, a strategic move that positions the company to capitalize on the rapidly expanding gut health market. This transaction represents a synergistic fit between LifeVantage's cellular-level activation technologies and LoveBiome's microbiome expertise, creating a more comprehensive wellness offering.
The deal's structure focuses on acquiring LoveBiome's core operational assets and retaining key personnel, including founder Kelly Olsen. This approach minimizes integration risks while preserving the intellectual capital that drives LoveBiome's value proposition.
From a strategic perspective, this acquisition delivers three primary benefits: product diversification into the growing microbiome health segment, geographic expansion in the US, Taiwan, and European markets, and potential distribution synergies through their combined direct sales networks.
The specific mention of LoveBiome's P84 product suggests it may serve as a flagship offering in this new category for LifeVantage. By leveraging LifeVantage's established compensation structure and distribution channels, the combined entity appears positioned to accelerate the market penetration of these microbiome solutions beyond what LoveBiome could achieve independently.
While financial terms weren't disclosed, the transaction aligns with industry consolidation trends in the wellness and direct sales sectors, where established players are acquiring innovative smaller companies to access new product categories and customer segments without lengthy in-house development timelines.
Strategic acquisition strengthens leadership position in direct sales and gut and microbiome health market
SALT LAKE CITY, Oct. 02, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced the closing of its previously announced acquisition of LoveBiome, a pioneering direct sales company dedicated to comprehensive microbiome care and wellness solutions. Under the terms of the completed transaction, LifeVantage has acquired LoveBiome's critical operating assets essential to the microbiome health business, including the retention of key LoveBiome personnel.
"We are pleased to have closed the LoveBiome acquisition and look forward to working with Kelly Olsen and the LoveBiome team to accelerate growth by leveraging their innovative microbiome solutions with our proven Activation technologies as one LifeVantage," said Steve Fife, President and CEO of LifeVantage. "This strategic transaction expands our product portfolio into the rapidly growing gut health market while also broadening our reach in key markets including the US, Taiwan, and Europe, underscoring our deep commitment to our mission of offering people around the world a better path to wellness through Activation.”
"We are excited to be part of LifeVantage and believe the partnership will allow us to achieve our aggressive growth plans," explained Kelly Olsen, founder and CEO of LoveBiome. "By combining our innovative P84 product with LifeVantage's proven Activation technologies and innovative compensation plan, we're positioned to activate wellness for a broader base of consumers and entrepreneurs."
About LifeVantage Corporation
LifeVantage Corporation (Nasdaq: LFVN), the Activation company, is a pioneer in nutrigenomics—the study of how nutrition and naturally occurring compounds can unlock your genes and the health coded within. Our products work with your unique biology and help your body make what it needs for health. The line of scientifically validated activators includes the flagship Protandim® family of products, TrueScience® Liquid Collagen, the newest MindBody GLP-1 System™, Activation-supporting nutrients such as Omega, D3+, and the Rise AM & Reset PM System®, as well as AXIO® nootropic energy drink mixes, the full TrueScience® line of skin and hair care products, and Petandim®, a pet supplement formulated to combat oxidative stress in dogs. Our independent Consultants sell our products to Customers and share the business opportunity with entrepreneurs seeking to begin their own business. LifeVantage is headquartered in Lehi, Utah. For more information, visit www.lifevantage.com.
Cautionary Note Regarding Forward Looking Statements
This document contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Words and expressions reflecting optimism, satisfaction or disappointment with current prospects, as well as words such as "believe," "will," "hopes," "intends," "estimates," "expects," "projects," "plans," "anticipates," "look forward to," "goal," “may be,” and variations thereof, identify forward-looking statements, but their absence does not mean that a statement is not forward-looking. The declaration and/or payment of a dividend during any quarter provides no assurance as to future dividends, and the timing and amount of future dividends, if any, could vary significantly in comparison both to past dividends and to current expectations. Examples of forward-looking statements include, but are not limited to, expected financial performance, including revenue and margins, statements we make regarding executing against and the benefits of our key initiatives, future growth, including geographic and product expansion, and expected dividend payments in future quarters. Such forward-looking statements are not guarantees of performance and the Company's actual results could differ materially from those contained in such statements. These forward-looking statements are based on the Company's current expectations and beliefs concerning future events affecting the Company and involve known and unknown risks and uncertainties that may cause the Company's actual results or outcomes to be materially different from those anticipated and discussed herein. These risks and uncertainties include, among others, further deterioration to the global economic and operating environments, as well as those discussed in greater detail in the Company's Annual Report on Form 10-K and the Company's Quarterly Report on Form 10-Q under the caption "Risk Factors," and in other documents filed by the Company from time to time with the Securities and Exchange Commission (the “SEC”). The Company cautions investors not to place undue reliance on the forward-looking statements contained in this document. All forward-looking statements are based on information currently available to the Company on the date hereof, and the Company undertakes no obligation to revise or update these forward-looking statements to reflect events or circumstances after the date of this document, except as required by law.
Investor Relations Contact:
Reed Anderson, ICR
(646) 277-1260
reed.anderson@icrinc.com
Public Relations Contact:
CerconeBrownCompany
lifevantage@cerconebrown.com
FAQ
What companies are involved in the LifeVantage (LFVN) acquisition announced on October 2, 2025?
What markets will the LifeVantage-LoveBiome acquisition impact?
Who is Kelly Olsen and what is their role in the LifeVantage acquisition?
What products are included in the LifeVantage-LoveBiome acquisition?
How will the LoveBiome acquisition affect LifeVantage's business?
